Head and neck diagnostics – Historical origins
The head and neck cancers constitute 12% of all malignancies in the world and are prevalent in regions where there is high consumption of alcohol and tobacco. Ever since, Hippocrates – the first person to use the word “cancer” and probably the first person to divide tumors into benign and malignant, the modern head and neck oncology has undergone numerous changes over the last centuries.
View report description and TOC: http://www.marketdataforecast.com/market-reports/head-and-neck-cancer-diagnostics-market-49/
However, the cradle of head and neck oncology can be traced back to ancient Egypt and Greece with the first tumors treated at that time were either cutaneous and malignancies or cancers on the mucosal surfaces of the oral cavity. By 19th and 20th century, there was rapid development and understanding of head and neck oncology with diagnostic methods and treatment strategies having been developed in these two centuries. The majority of head and neck cancers are called squamous cell carcinomas and there exist tests, and diagnosis in the form of Endoscopy, Panorex films, CT scan, Biopsy, MRI, Blood Tests etc.
Global Head and Neck Cancer Diagnostic Market – An overview
The global head and neck cancer diagnostic market is valued at US $7.85 billion in 2016 that is projected to reach the US $14.26 billion by 2021 and is predicted to growth at a significant rate at a CAGR of nearly 11.52% during the forecast period. It is estimated that overall head and neck cancer accounts for more than 50,000 cases annually which are roughly 3% to 5% of all cancer incidences all over the globe. Males are more affected by head and neck cancer than females in the ratio ranging from 2:1 to 4:1.
Request for sample report: http://www.marketdataforecast.com/market-reports/head-and-neck-cancer-diagnostics-market-49/request-sample
Head & Neck Cancer (HNC) Market as per a reputed head and neck cancer market report is expected to increase every year with an increasing incidence of the head and neck cancer. The growth in head and neck cancer diagnostics market can be attributed to the advances being made in the chemotherapy and other treatment options and an increase in the per capita income of the people, especially in the developed economies.
In addition, the head and neck cancer is the seventh most common cancer worldwide with an estimated 700,000 new cases diagnosed globally each year necessitating better healthcare initiatives to be taken by governments and various private health or medical institutions/hospitals in detecting head and neck cancer through various diagnostic methods available in the head and neck cancer diagnostic market. Some negative factors are inhibiting the growth of global head and neck cancer diagnostic market such as high cost of targeted therapies and low awareness about the technological advances and novel therapies for the treatment of head and neck cancer especially in developing economies.
Market Segmentation of Head and Neck Cancer Diagnostic Market
The global head and neck cancer diagnostic market are aptly segmented based on Type of Cancer, Diagnostic Technique, Type of Treatment and End User. Each of these is further divided as per their functionalities as shown below in a tabular format.
Type of Cancer
|Diagnostic Technique||Type of Treatment||End User|
|Salivary Gland Cancer||Biopsy||Surgery||Hospitals|
|Oropharyngeal (Oral Cavity) Cancer||Blood Tests||Chemotherapy||Ambulatory Surgical Centers|
|Nasopharyngeal Cancer||Diagnostic Imaging Equipment – PET/CT Scan, MRI & X-ray||Radiation Therapy||Clinics|
|Laryngeal Cancer||Endoscopy Screening — Pharyngoscopy, Laryngoscopy||Targeted Therapy|
|Others||Dental Diagnostic Equipment||Others||
Table: 1 – Market Segmentation of Head and Neck Cancer Diagnostic Market
In terms of revenue – the diagnostic imaging equipment segment holds the maximum market share in 2016 under the diagnostic technique segment. Radiation therapy has emerged as the most preferred type of treatment therapy, which is expected to dominate in addition to surgery segment in the coming decades due to the rising prevalence of hand and neck cancer among the global population.
The hospital’s segment occupies the leading share in the global head and neck cancer due to favorable reimbursement options or health policies being provided by both government and private health sector in addition to the availability of qualified and specialized physicians in hospitals.
Geographically, North America accounts for a major share of the Global Head and Neck Cancer Diagnostics Market due to technological advancements in the medical sector in this region. However, the Asia-Pacific region is emerging as the growing market for head and neck cancer diagnostic market due to higher intake of alcoholic and tobacco products among the population leading to rising cases of head and neck cancer. Overall, in the coming decades, the biggest markets for head and cancer diagnostic market would emerge from countries like India, China, and South Africa.